Tracy Mahvan, PharmD, MBA, BCGP

For pharmacists wondering whether bismuth quadruple therapy still reigns as the gold standard, the wait is over—the latest recommendations are here.

An increase in the use of GLP-1 agonists for weight loss is affecting patients with diabetes who rely on these medications.